Novo Nordisk | NVO - Actif À Court Terme

Prix De L'Action
37.41
Variation Quotidienne
-0.01 -0.03%
Mensuellement
-3.63%
Annuel
-42.20%
Q2 Prévisions
35.64




Actif À Court Terme Changement Date
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Aurora Cannabis CAD 445.84M 22M 2025-12
Bausch Health Companies USD 6.16B 92M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Drreddys Laboratories INR 3.31B 164.26M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Novo Nordisk DKK 25.71B 148.69B 2025-06
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Sanofi EUR 30.95B 3.09B 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Zoetis USD 6.77B 185M 2025-12